Lupin to launch launch a novel injectable iron formulation under brand names “Isofer” and “Jilazo” in India
Lupin, India based drug maker, will launch a novel injectable iron formulation from a Danish firm under brand names “Isofer” and “Jilazo” in India.
Formaulation: A novel Iron Isomaltoside 1000 injectable iron formulation.
Lupin has acquired exclusive rights to market, distribute, sell the formulation from Denmark based Pharmacosmos A/S.
The product is currently marketed in 33 countries, including 21 EU countries under the brand name Monofer.
Monofer Brand Positioning Statement: High dose iron in one visit
- Monofer is an IV iron treatment that gives you the possibility to treat patients with iron deficiency anaemia1. With Monofer many of your patients can be treated with high dose iron in just one visit2.
- Monofer is indicated for the treatment of iron deficiency when oral iron preparations are ineffective or cannot be used, or where there is a clinical need to deliver iron rapidly*.
- Reference: http://www.monofer.com/ more details. Monofer is the brand of Pharmacosmos A/S.